Delta-Fly Pharma Inc (4598)

Currency in JPY
105.0
-1.0(-0.94%)
Closed·
4598 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
105.0107.0
52 wk Range
92.0700.0
Key Statistics
Bid/Ask
105.00 / 107.00
Prev. Close
106
Open
105
Day's Range
105-107
52 wk Range
92-700
Volume
70.4K
Average Volume (3m)
196.59K
1-Year Change
-83.8462%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4598 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Delta-Fly Pharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
-30.23 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4598 Income Statement

Compare 4598 to Peers and Sector

Metrics to compare
4598
Peers
Sector
Relationship
P/E Ratio
−0.9x−9.2x−0.3x
PEG Ratio
−0.03−0.380.00
Price/Book
45.5x3.4x2.6x
Price / LTM Sales
-20.1x3.1x
Upside (Analyst Target)
-132.0%49.0%
Fair Value Upside
Unlock5.3%6.3%Unlock

Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase 1/2 clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. The company was incorporated in 2010 and is headquartered in Tokushima, Japan.

Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.34M16.38%248.33M
Public Companies & Retail Investors
11.96M83.62%1.27B
Total
14.3M100.00%1.52B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SBI Holdings, Inc.4.24%606,33464,271
Morgan Stanley3.90%558,00059,148

FAQ

What Is the Delta-Fly Pharma (4598) Stock Price Today?

The Delta-Fly Pharma stock price today is 105.0 JPY.

What Stock Exchange Does Delta-Fly Pharma Trade On?

Delta-Fly Pharma is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Delta-Fly Pharma?

The stock symbol for Delta-Fly Pharma is "4598."

What Is the Delta-Fly Pharma Market Cap?

As of today, Delta-Fly Pharma market cap is 1.5B JPY.

What Is Delta-Fly Pharma's Earnings Per Share (TTM)?

The Delta-Fly Pharma EPS (TTM) is -140.4.

When Is the Next Delta-Fly Pharma Earnings Date?

Delta-Fly Pharma will release its next earnings report on Nov 16, 2026.

From a Technical Analysis Perspective, Is 4598 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Delta-Fly Pharma Stock Split?

Delta-Fly Pharma has split 0 times.

What is the current trading status of Delta-Fly Pharma (4598)?

As of Aug 18, 2026, Delta-Fly Pharma (4598) is trading at a price of 105.0 JPY, with a previous close of 106.0 JPY. The stock has fluctuated within a day range of 105.0 JPY to 107.0 JPY, while its 52-week range spans from 92.0 JPY to 700.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.